Skip to content

Study on the efficacy of acupuncture and moxibustion treatment for opioid-induced constipation in cancer pain patients

Efficacy of Acupuncture and moxibustion Treatment for Opioid-Induced Constipation in Patients with Cancer Pain. An Open-Label, Randomized Controlled Trial - Acupuncture and moxibustion treatment for constipation in cancer patients (RCT)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047261
Enrollment
40
Registered
2022-03-23
Start date
2022-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignancy

Interventions

1. Early intervention group The pace of treatment will be twice a week for 3 weeks (6 sessions in total). The treatment will take place at the University Hospital&#39
s palliative care outpatient clinic and in the hospital ward, and treatment will be given on the patient&#39
s bed. Moxibustion is performed using an electronic moxibustion device to avoid the problem of smoke. The moxibustion should be applied to the same acupuncture points for 20 to 30 minutes at a time.

Sponsors

Kagawa University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Standard pharmacotherapy based on the WHO method for the treatment of cancer pain is being implemented. 2) Opioid-induced constipation symptoms are present 3) Acupuncture treatment is indicated. 4) Must be at least 20 years old

Exclusion criteria

Exclusion criteria: 1) Patients judged to have a high probability of complicated skin inflammation or infection (subjective judgment of the physician in charge is allowed). 2) Patients with an immediate and obvious life-threatening condition. 3) Other patients deemed inappropriate by the study physician.

Design outcomes

Primary

MeasureTime frame
Constipation assessment scale (CAS)

Secondary

MeasureTime frame
Visual Analogue Scale (VAS) Support Team Assessment Schedule Japanese (STAS-J) Drug Dose

Countries

Japan

Contacts

Public ContactKanae Kanda

Kagawa University Department of Public Health, Faculty of Medicine

kanda.kanae@kagawa-u.ac.jp0878912133

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026